AMILI
amili.asia
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
AMILI runs Southeast Asia's first gut microbiome bank and offers microbiome testing and therapeutic research. Its data addresses the under-representation of Asian populations in microbiome science. The company is headquartered in Singapore.
News
Brand new: GNC, AMILI, Kirin, a2 milk in the spotlight
See new developments from health and nutrition brands across Asia-Pacific, including GNC's new retail plans in Singapore, AMILI's metabolic health synbiotic launch, Kirin's plan to acquire Jamieson Wellness, a2mc's new scientific findings and more.
Read more
Report
Precision nutrition for Asia: AMILI and ASTAR to decode links between diet, microbiome, and metabolic health
Singapore biotech outfit AMILI and public sector R&D agency ASTAR has launched Project REMEDY to explore how Asian diets impact gut health and metabolism.
Read more
Report
Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science
Read more
Report
Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science
LONDON, Feb. 13, 2025 /PRNewswire/ -- Sequential Skin Ltd, a world leader in skin microbiome testing, and AMILI, a leading expert in gut microbiome science, are proud to announce that they have been awarded the prestigious UK-Singapore Collaborative R&D G
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Singapore
Singapore
HQ